Anuj Gaggar - 29 Mar 2025 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
Chief Medical Officer
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Issuer symbol
ASMB
Transactions as of
29 Mar 2025
Net transactions value
$0
Form type
4
Filing time
01 Apr 2025, 16:05:03 UTC
Previous filing
13 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASMB Stock Option (right to buy) Award $0 +24,200 $0.000000 24,200 29 Mar 2025 Common Stock 24,200 $10.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029.